AYERS JONATHAN W 4

4 · IDEXX LABORATORIES INC /DE · Filed May 8, 2024

Form 4

Period: 2024-05-06

Chairman, President & CEO

Transactions

Exercise/Conversion
Common Stock
2024-05-06+257→ 265,651 total
Award
Non-Qualified Stock Option (right-to-buy)
2024-05-06+609→ 609 total
Exercise: $476.87Exp: 2034-05-05→ Common Stock (609 underlying)
Award
Restricted Stock Unit
2024-05-06+262→ 262 total
→ Common Stock (262 underlying)
Exercise/Conversion
Restricted Stock Unit
2024-05-06−257→ 0 total
→ Common Stock (257 underlying)

Holdings

Footnotes (4)

[F1]The reporting person is the grantor and trustee of the Jonathan W. Ayers 2022 GRAT (the 'GRAT'). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
[F2]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier.
[F3]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier.
[F4]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event was earlier.

Documents

1 file